Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhongli Bao
Institution:
Amphastar Pharmaceuticals, Inc. (United States)
Observed institution:
Amphastar Pharmaceuticals, Inc. (United States)
ORCID:
0000-0002-3796-9435
Observed ORCID:
0000-0002-3796-9435
OpenAlex ID:
A5075712611
Comparison of the Purity and Impurity of Glucagon-for-Injection Products under Various Stability Conditions
2022
·
Zhongli Bao
, Ya-Chi Cheng
, et al.
·
Scientia Pharmaceutica
·
17
PDF
Assessment of innate immune response modulating impurities in glucagon for injection
2022
·
Qingxia Han
, Zhongli Bao
, et al.
·
PLoS ONE
·
16
PDF
Secondary Structure Characterization of Glucagon Products by Circular Dichroism and Nuclear Magnetic Resonance Spectroscopy
2022
·
Zhongli Bao
, Ya-Chi Cheng
, et al.
·
Molecules
·
4
PDF
Analysis of aggregation profile of glucagon using SEC-HPLC and FFF-MALS methods
2024
·
Zhongli Bao
, Ya-Chi Cheng
, et al.
·
PLoS ONE
·
1
Show more works
View as search
Works count:
4
Citation count:
38
H-index:
3
I10-index:
2
Year
Topic
Type